As part of the national influenza immunisation programme, the Ministry of Health of the Kyrgyz Republic has procured supplies of a modern Russian anti-flu vaccine, Grippol® Plus. The vaccine will be shipped to Kyrgyzstan under the contract signed by the vaccine producer, NPO Petrovax Pharm, and the winner of the government tender, Farvater LLC. The anti-flu vaccine is also becoming available for public sale in the Kyrgyz market.
Petrovax Pharm has been exporting pharmaceutical products to the Kyrgyz Republic for over five years. Due to excellent quality and proven high performance, the Company's major products, Polyoxidonium, Longidaze, and Grippol® Plus, are widely used in medical practice throughout the country.
For eight years now, Petrovax Pharm has been the largest Russian producer of vaccines for the National Immunisation Schedule. The Company continues to expand geographically, supplying immunobiological medicines to Belarus, Ukraine, Kazakhstan, Armenia, Azerbaijan, Uzbekistan, and Slovakia, with the next step being a foray into EU (Czech Republic, Hungary, Poland), Middle East, and Latin America markets.